NCT06490939View on ClinicalTrials.gov

Clinical Trial of Efepoetin Alfa in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 29, 2024

Primary Completion Date

March 25, 2025

Study Completion Date

March 25, 2025

Conditions
Healthy
Interventions
DRUG

Efepoetin Alfa

Single-intravenous administration

Trial Locations (1)

04763

Hanyang University Medical Center, Seoul

Sponsors

Lead Sponsor

Genexine, Inc.
All Listed Sponsors
lead

Genexine, Inc.

INDUSTRY

NCT06490939 - Clinical Trial of Efepoetin Alfa in Healthy Subjects | Biotech Hunter | Biotech Hunter